Ropivacaine represses the ovarian cancer cell stemness and facilitates cell ferroptosis through inactivating the PI3K/AKT signaling pathway
Yi Lu(Shandong Provincial Hospital), Wei Li(Shandong Provincial Hospital), Hao Pan(Xidian University), Jinbao Mao(Shandong Provincial Hospital), Yu Wang(Chinese Academy of Sciences), Yanbing Xu(Shandong Provincial Hospital)
Cited by 36
Related Papers
The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor–Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy—MONARCH 2
|JAMA Oncology|2019|1k
Single-cell analysis of pancreatic ductal adenocarcinoma identifies a novel fibroblast subtype associated with poor prognosis but better immunotherapy response
|Cell Discovery|2021|300
MONARCH plus: abemaciclib plus endocrine therapy in women with HR+/HER2– advanced breast cancer: the multinational randomized phase III study
|Therapeutic Advances in Medical Oncology|2020|110